Canadian Respiratory Journal

Non-Invasive Ventilation: Novel Insights into the Old Tool

Publishing date
01 Aug 2021
Submission deadline
19 Mar 2021

Lead Editor

1All India Institue of Medical Sciences, New Delhi, India

2Hospital Morales Meseguer, Murcia, Spain

3Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

4Monaldi Hospital, Naples, Italy

5Lenox Hill Hospital, New York, USA

6The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

This issue is now closed for submissions.
More articles will be published in the near future.

Non-Invasive Ventilation: Novel Insights into the Old Tool

This issue is now closed for submissions.
More articles will be published in the near future.


Non-invasive ventilation (NIV) is well-established in clinical practice and has saved many lives over the past few decades. It has helped in reducing rates of intubation and mechanical ventilation in patients with chronic obstructive pulmonary disease (COPD). Additionally, it has been widely used in patients with hypoxemic respiratory failure, postoperative respiratory failure, and neuromuscular disorders. Thus, it has helped in improving clinical outcomes and reducing complications related to mechanical ventilation, thereby reducing hospital resource utilization.

NIV is an evolving therapy with many emerging indications. The use of NIV has expanded from acute respiratory failure to domiciliary use for chronic hypercapnic respiratory failure in COPD, obesity hypoventilation syndrome, and neuromuscular weakness. NIV is now being used to assist bronchoscopies in patients with respiratory failure. In addition, there is a wider array of interventions to choose from with the advent of newer modes of NIV and alternate non-invasive therapies such as high-flow nasal cannula (HFNC) therapy. Nonetheless, challenges remain with this modality including sub-optimal use, patient discomfort, secretion retention, etc. Hence, there is a need for new information regarding humification, aerosol therapy, secretion clearance, and optimization of patient compliance.

In the context of the expanding repertoire and existing challenges, this Special Issue invites new insights in relation to the use of NIV. The aim of this Issue is to help readers of the journal to update their knowledge regarding optimal use of NIV in a wide variety of clinical situations. Original research and review articles are welcome.

Potential topics include but are not limited to the following:

  • Optimising compliance and patient outcomes
  • Newer indications of NIV
  • Issues related to NIV use such as humidification and secretion management
  • Aerosol therapy during NIV
  • Description of newer modes in combination with other therapies such as HFNC
  • NIV use during interventions
  • NIV in specific situations such as COVID-19
Canadian Respiratory Journal
 Journal metrics
See full report
Acceptance rate18%
Submission to final decision105 days
Acceptance to publication19 days
Journal Citation Indicator0.460
Impact Factor2.130

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.